Eli Lilly's Efsitora Meets Key Endpoints in Phase III Trials for Type 2 Diabetes
CompanyDrug

Eli Lilly’s Efsitora Meets Key Endpoints in Phase III Trials for Type 2 Diabetes

Johnson & Johnson's Imbruvica Secures CHMP Recommendation for Expanded MCL Use
CompanyDrug

Johnson & Johnson’s Imbruvica Secures CHMP Recommendation for Expanded MCL Use

Bayer's Nubeqa Receives Positive CHMP Opinion for mHSPC Treatment
CompanyDrug

Bayer’s Nubeqa Receives Positive CHMP Opinion for mHSPC Treatment

Boao Lecheng Partners with China National Center for Neurological Diseases to Establish Translational Center
CompanyDeals

Boao Lecheng Partners with China National Center for Neurological Diseases to Establish Translational Center

Sichuan Huiyu's CDCP1-Targeted ADC HY0001a Gets NMPA Clinical Trial Approval
CompanyDrug

Sichuan Huiyu’s CDCP1-Targeted ADC HY0001a Gets NMPA Clinical Trial Approval

Changshan Biochemical Receives NMPA Clearance for Albenatide in Weight Loss Trials
CompanyDrug

Changshan Biochemical Receives NMPA Clearance for Albenatide in Weight Loss Trials

ImmuneOnco Receives NMPA Approval for IMC-003/IMM72 in Pulmonary Arterial Hypertension Trial
CompanyDrug

ImmuneOnco Receives NMPA Approval for IMC-003/IMM72 in Pulmonary Arterial Hypertension Trial

United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare
CompanyDeals

United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare

MGI Tech's DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry
CompanyMedical Device

MGI Tech’s DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry

CompanyDeals

Jiangxi Rimag to Acquire 70% Stake in Guangzhou Gaomai for RMB 54 Million

Simcere Pharma's Quviviq Receives NMPA Approval for Insomnia Treatment
CompanyDrug

Simcere Pharma’s Quviviq Receives NMPA Approval for Insomnia Treatment

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment
CompanyDrug

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment